Understand Changing Risk. Support More Personalized Prevention.
For people living with cancer, thrombosis can become a serious complication. Risk is not the same for every patient—and it may change during treatment, recovery and follow-up.
Why this matters
Cancer type, treatment, clinical history and other patient-specific factors can influence thrombotic risk. Clinicians must interpret complex information while balancing the potential benefits of preventive strategies against bleeding risk and other considerations. A one-time assessment may not reflect a changing clinical situation.
Personalized assessment—not a generic warning.
MedAIQ is exploring specialized predictive algorithms that bring together clinically relevant factors to support individualized thrombosis-risk assessment. The intended role is to help healthcare professionals recognize patients who may need closer evaluation, review risk as circumstances change and consider evidence-informed prevention and follow-up plans.
Intelligence that supports each stage
Understand the individual
Consider clinically relevant patient factors, treatment context and available medical information.
Assess evolving risk
Use validated approaches, when available, to identify patterns that may warrant clinician review.
Inform prevention planning
Provide decision-supporting information for qualified clinicians to weigh appropriate options and potential harms.
Review over time
Support reassessment as treatment, patient status and the evidence base change.
Designed around real clinical needs
For patients
The possibility of more individualized attention and informed conversations about risk.
For oncology teams
A structured view of relevant risk information that may complement clinical judgment.
For care pathways
Opportunities to connect assessment, prevention planning and follow-up across settings.